Simvastatin Versus MTA in Pulpotomy of Immature Permanent Molars

• Status: Recruiting
• Trial end date: 2024-09-01
• Target enrollment: 0
• Participant gender: All

Summary

the study will be done to evaluate the clinical and digital radiographic success of simvastatin versus MTA in pulpotomy of immature permanent molars

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ahmad Elheeny
• Treatments: Simvastatin

Criteria

Inclusion Criteria:

• Healthy children aged from 6 to 8 years

• Children with severe behavioral, or emotional disabilities, and medically compromised children will be excluded.

• Deep carious lesions of the first permanent immature molars with signs & symptoms of reversible pulpitis will be included

• Normal radiographic findings and immature roots